1,060
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs

, , , , , , , & show all
Pages 490-493 | Received 17 Mar 2016, Accepted 19 Jul 2016, Published online: 10 Aug 2016

Figures & data

Table 1. Mean, standard deviation, minimum and maximum values, and inferior (Inf) and superior (Sup) 95% confidence intervals for IGF-1 serum levels (ng/mL) in PRGF- and HPRGF-injected dogs at each study period.

Table 2. Mean, standard deviation, minimum and maximum values, and inferior (Inf) and superior (Sup) 95% confidence intervals for CRP serum levels (µg/mL) in PRGF- and HPRGF-injected dogs at each study period.

Figure 1. Evolution of IGF-1 levels in PRGF- and HPRGF-injected dogs at various time periods (logarithmic scale) up to three days post injection.

Figure 1. Evolution of IGF-1 levels in PRGF- and HPRGF-injected dogs at various time periods (logarithmic scale) up to three days post injection.

Figure 2. Evolution of CRP levels in PRGF- and HPRGF-injected dogs at various time periods (logarithmic scale) up to three days post injection.

Figure 2. Evolution of CRP levels in PRGF- and HPRGF-injected dogs at various time periods (logarithmic scale) up to three days post injection.